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Abstract
Background: Long-term asthma management falls short of the goals set by international guidelines. The Internet is proposed
as an attractive medium to support guided self-management in asthma. Recently, in a multicenter, pragmatic randomized controlled
parallel trial with a follow-up period of 1 year, patients were allocated Internet-based self-management (IBSM) support (Internet
group [IG]) or usual care (UC) alone. IBSM support was automatically terminated after 12 months of follow-up. In this study,
IBSM support has been demonstrated to improve asthma-related quality of life, asthma control, lung function, and the number
of symptom-free days as compared to UC. IBSM support was based on known key components for effective self-management
and included weekly asthma control monitoring and treatment advice, online and group education, and communication (both
online and offline) with a respiratory nurse.
Objective: The objective of the study was to assess the long-term effects of providing patients 1 year of IBSM support as
compared to UC alone.
Methods: Two hundred adults with physician-diagnosed asthma (3 or more months of inhaled corticosteroids prescribed in the
past year) from 37 general practices and 1 academic outpatient department who previously participated were invited by letter for
additional follow-up at 1.5 years after finishing the study. The Asthma Control Questionnaire (ACQ) and the Asthma Quality of
Life Questionnaire (AQLQ) were completed by 107 participants (60 UC participants and 47 IG participants). A minimal clinical
important difference in both questionnaires is 0.5 on a 7-point scale.
Results: At 30 months after baseline, a sustained and significant difference in terms of asthma-related quality of life of 0.29
(95% CI 0.01-0.57) and asthma control of -0.33 (95% CI -0.61 to -0.05) was found in favor of the IBSM group. No such differences
were found for inhaled corticosteroid dosage or for lung function, measured as forced expiratory volume in 1 second.
Conclusions: Improvements in asthma-related quality of life and asthma control were sustained in patients who received IBSM
support for 1 year, even up to 1.5 years after terminating support. Future research should be focused on implementation of IBSM
on a wider scale within routine asthma care.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 79864465;
http://www.controlled-trials.com/ISRCTN79864465 (Archived by WebCite at http://www.webcitation.org/6J4VHhPk4).
(J Med Internet Res 2013;15(9):e188)   doi:10.2196/jmir.2640
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Introduction
Asthma is a common chronic disease with a prevalence of
approximately 6% among adults [1]. It is characterized by
chronic inflammation and/or structural changes of the airways,
which leads to recurrent episodes of wheezing, coughing,
difficulty breathing, and/or chest tightness [2,3]. According to
clinical guidelines [2,3], treatment strategies for asthma should
be aimed at minimization of symptoms, optimization of lung
function, and prevention of symptom aggravation with few
medication side effects. Even though effective therapies are
widely available, many patients do not achieve these treatment
goals [1,4]. As a consequence, asthma still imposes a significant
burden of disease on the individual patient. A proactive
patient-centered approach consisting of education, treatment
goals, self-monitoring, and an action plan, accompanied by
guidance and regular review by a health care provider, has the
potential to improve outcomes in asthma [5], including improved
quality of life and a reduced number of hospitalizations and
unscheduled doctor visits. In spite of the prominent role within
guidelines, adoption of this “guided self-management” is lacking
[6]. While many practices do offer patients a routine medical
review, only a minority of patients are provided with an action
plan by their health care provider [7,8]. Usage of action plans
by patients could be enhanced if action plans are part of a
patient-professional partnership and when they are tailored to
the needs of the individual patient [9].
Provision of Internet technology has been proposed as an
appealing medium for asthma management [10-14]. Indeed, in
the study by Van der Meer et al [15] in patients with mild to
moderate persistent asthma, it was demonstrated that provision
of an Internet-based self-management (IBSM) support program
for 1 year leads to improved asthma-related quality of life,
asthma control, lung function, and the number of symptom-free
days as compared to usual care (UC) alone. A post hoc analysis
of this study [16] demonstrated that patients with asthma that
was not well controlled benefited the most from IBSM support.
In addition, this study showed that at 12 months of follow-up,
about 60% of the patients were still using the program of their
own initiative. However, it is unknown whether the benefits are
sustained over a long-term period. We hypothesized that the
benefits of providing 1 year of IBSM support are sustained over
a long-term period.
In this paper, we aim to assess the long-term effects of providing
patients 1 year of IBSM support as compared to UC alone.
Methods
Participants
Two hundred patients who previously participated in a 12-month
multicenter, nonblinded, pragmatic randomized controlled
parallel trial were invited for additional follow-up 1.5 years
after finishing the study. Full details of the study methodology
and subjects for the Self-Management of Asthma Supported by
Hospitals, ICT, Nurses and General practitioners (SMASHING)
study have been published elsewhere [15]. Briefly, patients were
recruited from 37 general practices in the Leiden and The Hague
area and from the outpatient clinic of the department of
Respiratory Medicine of the Leiden University Medical Center
(LUMC), the Netherlands. Eligibility criteria were adult age
(18-50 years), physician-diagnosed asthma, prescription of
inhaled corticosteroids ≥3 months in the previous year, access
to Internet at home, and the ability to understand written and
oral Dutch instructions. Patients who received a maintenance
dose of oral corticosteroids were excluded.
All participants were trained in a group educational session to
measure lung function as forced expiratory volume in 1 second
(FEV1) by using a handheld electronic spirometer (PiKo-1,
Ferraris Respiratory). After this session, patients were asked to
report during a 2-week period FEV1 (daily), day and night
symptom score (daily), and to fill in at least once weekly an
Asthma Control Questionnaire (ACQ) [17] on a specifically
designed website or by mobile phone text messaging (SMS).
The ACQ is a validated 7-item questionnaire for assessment of
actual level of asthma control, consisting of 6 questions on
asthma symptoms in the previous 7 days and an FEV1
measurement. Optimal cut-point for “well-controlled” is ≤0.75
and a value of ≥1.50 confirms “uncontrolled” asthma [18].
During these 2 weeks, patients did not receive feedback on their
actual level of asthma control.
After the 2-week period, all patients were randomized to either
IBSM support adjacent to UC, that is, Internet group (IG), or
to UC alone. Strategy allocation of patients on a 1:1 ratio was
conducted by JKS using a computer-generated permuted block
scheme. Patients were stratified on care provider (general
practice vs outpatient clinic) and asthma control at baseline.
The SMASHING study was powered to detect a difference in
the primary outcome asthma-related quality of life, as measured
by the Asthma Quality of Life Questionnaire (AQLQ) score
[19] between the two groups. Due to the nature of the
intervention and its pragmatic character, researchers were not
blinded for group allocation. This study was approved by the
ethical committee of the LUMC, the Netherlands, and was
conducted in concordance with the principles of the Declaration
of Helsinki [20], as amended in Seoul 2008. The trial conformed
to the Consolidated Standards of Reporting Trials
(CONSORT)-eHealth Checklist (Multimedia Appendix 1) [21].
Internet-Based Self-Management Support Program
The IBSM support program is based on focus groups [22], the
Chronic Care model [23], and known key components for
effective self-management [5]. The program was aimed at
supporting patients in conducting self-management activities
and developing a patient-provider partnership in asthma care
[3]. Focus groups were conducted to explore barriers for
conducting self-management skills and to identify the potential
role of an IBSM support tool. In particular, patients with asthma
that was not well controlled (ACQ>0.75) were motivated to use
novel information and communication technologies for
management of their disease. The Chronic Care model is aimed
at improving health care outcomes for patients with a chronic
disease by means of a proactive patient-professional partnership
that addresses both organizational factors (eg, decision support
systems) and resources (eg, self-management support). We
incorporated modules for electronic monitoring of asthma
control and lung function (weekly ACQ and FEV1), a personal
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action plan, communication with a respiratory nurse (RN), and
education.
During 12 months of follow-up, IG patients had access to IBSM
support (Multimedia Appendix 2); after this period, IBSM
support (including access to the website) was automatically
terminated. Patients were instructed on how they could log in
by using a personal username and password and how to use
their personal action plan. The program included reminder
options for monitoring activities (ie, ACQ, day and night
symptom score, lung function), which were initially sent once
weekly by either email or mobile phone SMS text messaging,
but during follow-up frequency could be adjusted according to
the preferences of the individual patient. Patients received
immediate feedback (to maintain, step up or step down in
medication, and/or to contact a health care professional) on
self-monitoring outcomes according to a treatment algorithm
(Figure 1) and a predefined action plan based on 6 medication
steps (Table 1).
Five respiratory physicians, two general practitioners with a
particular focus on respiratory diseases, and two respiratory
epidemiologists participated in the development of this
algorithm. Action plans of patients were based on their actual
medication at the time of study enrollment. Treatment steps
corresponded with (inter) national guidelines [3,24] on asthma
management. Briefly, asthma medication can be aimed at (1)
decreasing of airway narrowing (ie, beta2-agonists), and/or (2)
decreasing airway inflammation (ie, glucocorticosteroids,
leukotriene modifiers). A traffic light display (Figure 2) was
used to indicate the level of asthma control: green
(well-controlled, ACQ≤0.5), yellow (0.5<ACQ<1.0), orange
(1.0<ACQ<1.5), and red (uncontrolled, ACQ score≥1.50).
After each medication change, a 4-week evaluation period
commenced during which no advice to change treatment was
given, except in the case of symptom deterioration. E-messaging,
telephone, or Web-based communication allowed patients to
interact with the RN. Additionally, the RN supported patients
by nurse-initiated communication characterized by a supportive
style to give positive feedback on achieved successes (eg,
step-down in medication) or to inquire for reasons on not
following treatment advice (eg, side effects). The RN reminded
patients to fill in research questionnaires at 12 months of
follow-up. On average, the RN spent 1-2 hours per week on
patient- and nurse-initiated communication for all IG patients.
Education components of IBSM support were provided both
online (eg, educational pages, newsfeed) and offline. Offline
education consisted of a group education session that dealt with
topics related to asthma self-management, usage of the IBSM
tool, and designing an action plan based on current medication.
Online information was based on information provided by the
Lung Foundation Netherlands. Newsfeed content was kept up
to date and contained items related to asthma and management
of chronic diseases (eg, healthy lifestyle). During the study,
neither major content/functionality changes nor bug fixes were
required.
Program content was developed by JKS in close collaboration
with the departments of Public Health and Primary Care
(LUMC), Respiratory Medicine (LUMC, Amsterdam Medical
Center), and Haga Teaching Hospital, The Hague. Software
was developed by Furore BV, Amsterdam.
Table 1. Medication treatment steps.
MedicationStepa
As needed rapid-acting beta2-agonistb1
Low-dose inhaled glucocorticosteroids2
Low-dose inhaled glucocorticosteroids + long-acting beta2-agonist3a
Medium-dose inhaled glucocorticosteroids3b
High-dose inhaled glucocorticosteroids3c
Medium-dose inhaled glucocorticosteroids + long-acting beta2-agonist4a
High-dose inhaled glucocorticosteroids + long-acting beta2-agonist4b
Contact RN or other health care provider: consider addition of leukotriene modifier4c
Contact RN or other health care provider: consider addition of oral glucocorticosteroids5
aStep numbers correspond with GINA guideline treatment steps [3].
bApplies to all treatment steps as this is reliever medication.
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Figure 1. Treatment algorithm.
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Figure 2. Traffic light display.
Usual Care
Patients allocated to UC received care as usual by their health
care provider. According to the Dutch College of General
Practitioners [24], each patient should be provided with a
(paper-based) action plan and be invited for a medical review
at least once a year.
Additional Follow-Up 30 Months After Baseline
Patients who previously participated were invited, by a letter
containing information on the follow-up measurements, to attend
the LUMC for follow-up measurements at 30 months after
baseline (Table 2). Nonresponding patients received a reminder
letter within 2-4 weeks and an additional telephone call. All
participants gave written informed consent during this visit,
prior to obtaining measurements. Patients were asked to report
on their daily dose of inhaled corticosteroids (ICS) and to
complete 2 paper-based questionnaires, namely an ACQ
(including FEV1) and an AQLQ [19], a validated 21-item
questionnaire for assessment of asthma-related quality of life.
The minimal clinical important difference for the ACQ is -0.5
and for the AQLQ is 0.5 [25,26]. Both questionnaires have a
7-point scale. Patients were asked to withhold short-acting
beta2-agonists for 6-8 hours prior to FEV1 measurement.
Questionnaires were sent in the mail to patients who were unable
or unwilling to attend the LUMC, and an additional home visit
was scheduled in case of unavailability of a Piko-1 meter.
Inhaled corticosteroid doses were reported as fluticasone
equivalents.
Statistical Analysis
Differences in characteristics at baseline (null months) were
analyzed between participants and nonparticipants of both
groups (UC and IG) with unpaired t tests. ACQ and AQLQ
scores, FEV1, and daily ICS dose were compared between
participants from both groups by applying linear mixed-effect
models. ICS doses were reported as fluticasone equivalents.
Within- and between-group differences were analyzed with
paired and unpaired t tests, respectively. Statistical analyses
were carried out by intention to treat. For analysis, Stata 9.2
was used. Subgroup analyses were conducted for patients with
well-controlled (ACQ≤0.75) and uncontrolled asthma
(ACQ>0.75) [17] at baseline.
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Table 2. Outcome measures.
IBSM support (IG only)Characteristics
30 months/additional follow-up12 months3 monthsBaseline
Clinical
XXXXAsthma control (ACQ)
XXXXLung function (FEV1)
XXXXDaily inhaled corticosteroid
Quality of life
XXXXAsthma-related quality of life (AQLQ)
Results
Characteristics
In total, 107 out of 200 (54%) invited patients consented to
participate for additional follow-up at 1.5 years after finishing
the SMASHING study (Figure 3), of whom 60 patients were
previously allocated to UC and 47 patients to the IG.
Participants in the IG differed in baseline ACQ scores from
nonparticipants (0.93 vs 1.29; P=.009). Apart from these
differences, no other differences in clinical characteristics at
baseline between participants and nonparticipants in each group
were identified. Table 2 gives an overview of baseline
characteristics of study participants. Baseline characteristics of
both groups were similar (Table 3).
Clinical Outcomes
Twelve months after baseline, significant improved outcomes
in favor of the IG were demonstrated for asthma-related quality
of life (AQLQ) at 0.37 (95% CI 0.14-0.61) and asthma control
of -0.57 (95% CI -0.88 to -0.26) as compared with UC. For
those who participated at 30 months, a difference in ACQ score
between baseline and 12 months was 0.43 (95% CI 0.21-0.66)
in favor of the IG. For those who did not participate at 30
months, a difference between baseline and 12 months of 0.34
(95% CI 0.06-0.61) in favor of the IG was detected. However,
there was no significant difference in effect (in ACQ score
between 0 and 12 months) between participants (0.43) and
nonparticipants (0.33) at 30 months.
At 30 months after baseline, a significant and slightly attenuated
improvement was shown for both AQLQ (adjusted
between-group difference 0.29 [95% CI 0.01-0.57]) and ACQ
(adjusted difference of -0.33 [95% CI -0.61 to -0.05]) scores in
favor of the IG (Figures 4 and 5). No such differences were
demonstrated for ICS dosage and lung function measured as
FEV1 (Figures 6 and 7). Patients with uncontrolled asthma at
baseline (ACQ≤0.75) had significant better outcomes at 30
months for AQLQ (adjusted within-group difference of 0.52
[95% CI 0.10-0.95]) and asthma control (adjusted difference
-0.44 [95% CI 0.04-0.85]) in favor of the IG.
Table 3. Baseline characteristics.
Usual care group
n=60
Internet group
n=47
Characteristics
37 (8.0)36 (8.7)Age, mean (SD)
Gender, n (%)
19 (32)12 (26)Male
41 (68)35 (74)Female
27 (45)25 (53)Smokers, n (%)
476 (338)455 (279)Inhaled corticosteroids (µg/day), mean (SD)
5.84 (0.82)5.88 (0.74)AQLQ score, mean (SD)a
0.97 (0.65)0.93 (0.60)ACQ score , mean (SD)b
3.41 (0.96)3.26 (0.80)Prebronchodilator FEV1, mean (SD)
c
95.5 (18)96.8 (20)Prebronchodilator FEV1 (% predicted), mean (SD)
c
aScore range (worst-best), 1-7; minimal clinical important difference (MCID): 0.5.
bScore range (worst-best), 6-0; MCID: 0.5.
cNumber of available observations in the Internet group is 26 and in the usual care group 37.
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Figure 3. Flowchart of study participants.
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Figure 4. Mean Asthma Quality of Life Questionnaire score for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.
Figure 5. Mean Asthma Control Questionnaire score for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.
J Med Internet Res 2013 | vol. 15 | iss. 9 | e188 | p.8http://www.jmir.org/2013/9/e188/
(page number not for citation purposes)
van Gaalen et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 6. Mean ICS dosage for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.
Figure 7. Mean FEV1 for the Internet and Usual care group as measured at 0, 3, 12, and 30 months of follow-up.
Discussion
Principal Findings
This study indicates that provision of IBSM support for 1 year
leads to sustained benefits in terms of asthma control and
asthma-related quality of life as compared with usual care, even
up to 1.5 years after terminating support. IBSM support was
additional to usual care and consisted of education, an action
plan, self-monitoring, and regular medical review. Therefore,
this study illustrates that sustained health improvements in health
can be achieved by a structured care approach and
self-management support as outlined by the Chronic Care model
[23]. To our knowledge, this is the first study on long-term
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outcomes of Internet-based comprehensive self-management
delivered to patients with asthma in primary care. In the study
by Thoonen et al [27], it was demonstrated that guided
self-management to patients with asthma in Dutch general
practice for 2 years leads to small but sustained benefits in
asthma control (except for lung function) and asthma-related
quality of life as compared to usual care.
Limitations
The original SMASHING study had several strengths, which
have been discussed at length elsewhere [15]. Briefly, the study
had a strong randomized controlled design without major
baseline differences between patients in both groups and was
characterized by a pragmatic attitude [28]. Nevertheless, results
of this follow-up measurement need to be interpreted with some
caution. First, our response rate was relatively low compared
to other long-term outcome studies [29], which might limit the
generalizability of our results. Second, even though a sustained
effect for both asthma control and asthma-related quality of life
in favor of the IG was demonstrated, these differences did not
reach the threshold of a clinical important difference (MCID).
However, we included patients with well-controlled asthma at
baseline. In contrast, the subgroup of patients with uncontrolled
asthma at baseline did show a clinical relevant difference in
terms of asthma-related quality of life. Patients with worse
asthma control have a larger room for improvement and could
therefore be more willing to participate in self-management
activities [30].
Even though IG patients had better outcomes in terms of asthma
control and asthma-related quality of life as compared with UC
patients, this difference was not accompanied with a higher ICS
dosage for IG patients. Whether this can be attributed to the
ability of the individual IG patient to tailor treatment to his or
her need remains unclear. Moreover, the propensity to change
in-treatment steps could have been reduced as guidance by
IBSM support was terminated.
To what extent demonstrated long-term benefits can be attributed
to the mode of delivery, beyond incorporating components
(education, monitoring, action plan, and regular review) for
effective self-management, remains unclear. More specifically,
whether the IBSM approach has led to improved
self-management skills can only be postulated as we did not
collect data on self-management outcomes, such as self-efficacy
or compliance. If self-management skills have been improved,
this is due to more intensive support in the start-up phase, since
at 12 months after baseline only about 60% of the patients were
still using the program on their own initiative [16]. This
illustrates that patients do not seem to develop dependence on
modern technology, a known barrier for both patients and
professionals for using modern technology for asthma
self-management support [31]. Moreover, it also suggests that
intensity of a self-management support program should be
tailored to the individual patient; once a patient has met his or
her personal objective, the intensity should be adjusted.
Recently, Ryan et al [32] compared a comprehensive
self-management approach for adults with poorly controlled
asthma (ACQ≥1.5) in general practice in which the monitoring
module was either paper-based or mobile phone-based. After
6 months follow-up, both patient groups had improved in terms
of asthma control and self-efficacy, but no difference was
demonstrated between groups. Clearly, this study does illustrate
that there is room for improvement in provision of routine
asthma care, since in both groups self-management was
delivered in concordance with asthma guidelines (consisting of
education, self-monitoring, action plan, and guidance by a
professional). Nevertheless, this does not imply that modern
technology might not be important since it does offer
opportunities to enhance adoption of self-management support
within routine care.
Conclusions
From a patient perspective, there is an increasing demand to
use modern technology in the management of chronic disease.
In asthma, this is illustrated by a growing number of available
apps for asthma “self-management” [33]. Unfortunately, these
apps are characterized not only by their lack of all components
for effective self-management but also by a lack of reliable
content.
Given the sustained benefits, cost-effectiveness becomes more
favorable for IBSM, since major intervention costs, such as
equipment and education sessions, apply to the first year, while
maintenance costs can be spread over a longer period and could
be improved by an increased number of users.
For successful adoption of IBSM within routine care and into
a patient’s daily life, several preconditions need to be identified
and addressed among stakeholders [34,35]. For instance, IBSM
support should address daily routines of patients, for example,
frequency of monitoring should be able to be adjusted to the
needs of the individual patient. From an organizational point of
view, an adequate infrastructure for asthma care (eg, routine
consultations) should be available within practices. Moreover,
technology should be integrated within the current available
digital infrastructure. At a professional level, (Internet-based)
self-management support requires a proactive role from the
health care provider, which allows for a patient-professional
partnership. Finally, from an economic point of view, financial
incentives such as adequate reimbursements of lung function
meters and consultations by health care insurance companies
could be considered. More research is needed on the question
of how to embed self-management support by means of modern
technology within routine practice.
A comprehensive Internet-based self-management approach
leads to sustained benefits in terms of asthma-related quality of
life and asthma control, even up to 1.5 years after terminating
support, particularly for patients with asthma that was not well
controlled at baseline. Future research is needed to gain insight
on long-term outcomes, cost-effectiveness, and strategies for
integration of self-management support by modern technology
in real-life settings.
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